Antimalarials inhibit hematin crystallization by unique drug-surface site interactions

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7531-7536. doi: 10.1073/pnas.1700125114. Epub 2017 May 30.

Abstract

In malaria pathophysiology, divergent hypotheses on the inhibition of hematin crystallization posit that drugs act either by the sequestration of soluble hematin or their interaction with crystal surfaces. We use physiologically relevant, time-resolved in situ surface observations and show that quinoline antimalarials inhibit β-hematin crystal surfaces by three distinct modes of action: step pinning, kink blocking, and step bunch induction. Detailed experimental evidence of kink blocking validates classical theory and demonstrates that this mechanism is not the most effective inhibition pathway. Quinolines also form various complexes with soluble hematin, but complexation is insufficient to suppress heme detoxification and is a poor indicator of drug specificity. Collectively, our findings reveal the significance of drug-crystal interactions and open avenues for rationally designing antimalarial compounds.

Keywords: P. falciparum; crystallization inhibition; hematin crystals; heme detoxification; malaria.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adsorption
  • Antimalarials / chemistry*
  • Binding Sites
  • Chloroquine / chemistry
  • Crystallization
  • Crystallography, X-Ray
  • Drug Evaluation, Preclinical
  • Heme / chemistry
  • Hemeproteins / chemistry*
  • Hemin / chemistry
  • Plasmodium falciparum / drug effects
  • Quinolines / chemistry*

Substances

  • Antimalarials
  • Hemeproteins
  • Quinolines
  • hemozoin
  • Heme
  • Hemin
  • Chloroquine